Veraflox (15 - 20 kg)
Active substance
ATC code
Species
Dogs, cats
Indications
Dogs:
Treatment of:
• wound infections caused by susceptible strains of the Staphylococcus intermedius group (including S. pseudintermedius),
• superficial and deep pyoderma caused by susceptible strains of the Staphylococcus intermedius group (including S. pseudintermedius),
• acute urinary tract infections caused by susceptible strains of Escherichia coli and the Staphylococcus intermedius group (including S. pseudintermedius) and
• as adjunctive treatment to mechanical or surgical periodontal therapy in the treatment of severe infections of the gingiva and periodontal tissues caused by susceptible strains of anaerobic organisms, for example Porphyromonas spp. and Prevotella spp. (see section 4.5).
Cats:
Treatment of acute infections of the upper respiratory tract caused by susceptible strains of Pasteurella multocida, Escherichia coli and the Staphylococcus intermedius group (including S. pseudintermedius).
Dose to be administered and administration route
Oral use.
Doses
The recommended dose is 3 mg/kg bodyweight of pradofloxacin once daily. Due to the available tablet sizes the resulting dose range is 3 to 4.5 mg/kg bodyweight according to the following tables.
To ensure a correct dose, bodyweight should be determined as accurately as possible to avoid under dosing. When the dose requires a half tablet to be used the remaining portion should be given at the next administration.
Dogs:
Bodyweight of Dog (kg) |
Number of tablets |
Pradofloxacin dose (mg/kg bw) |
||
15 mg |
60 mg |
120 mg |
||
>3.4 – 5 |
1 |
3 – 4.4 |
||
5 – 7.5 |
1½ |
3 – 4.5 |
||
7.5 – 10 |
2 |
3 – 4 |
||
10 – 15 |
3 |
3 – 4.5 |
||
15 – 20 |
1 |
3 – 4 |
||
20 – 30 |
1½ |
3 – 4.5 |
||
30 – 40 |
1 |
3 – 4 |
||
40 – 60 |
1½ |
3 – 4.5 |
||
60 – 80 |
2 |
3 – 4 |
Cats:
Bodyweight of Cat |
Number of tablets |
Pradofloxacin dose |
(kg) |
15 mg |
(mg/kg bw) |
>3.4 – 5 |
1 |
3 – 4.4 |
5 – 7.5 |
1½ |
3 – 4.5 |
7.5 – 10 |
2 |
3 – 4 |
Duration of treatment
The duration of the treatment depends on the nature and severity of the infection and on the response to treatment. For most infections the following treatment courses will be sufficient:
Dogs:
Indication |
Duration of treatment (days) |
Infections of the skin: |
|
Superficial pyoderma |
14 – 21 |
Deep pyoderma |
14 – 35 |
Wound infections |
7 |
Acute infections of the urinary tract |
7 – 21 |
Severe infections of the gingiva and periodontal tissues |
7 |
The treatment should be re-considered if no improvement of the clinical conditions is observed within 3 days, or in cases of superficial pyoderma 7 days, and in cases of deep pyoderma 14 days, after starting the treatment.
Cats:
Indication |
Duration of treatment (days) |
Acute infections of the upper respiratory tract |
5 |
The treatment should be re-considered if no improvement of the clinical condition is observed within 3 days after starting the treatment.
Adverse reactions
Mild transient gastro-intestinal disturbances including vomiting have been observed in rare cases in dogs and cats.
The frequency of adverse reactions is defined using the following convention:
- very common (more than 1 in 10 animals treated displaying adverse reactions)
- common (more than 1 but less than 10 animals in 100 animals treated)
- uncommon (more than 1 but less than 10 animals in 1,000 animals treated-)
- rare (more than 1 but less than 10 animals in 10,000 animals treated)
- very rare (less than 1 animal in 10,000 animals treated, including isolated reports).
References
PRICE | Only for registered vets. Create a free profile to access all features.. Login |
---|---|
Art. Nr. | 04895/5011 |